Date: 26 October 2021 - 8 November 2021
Organiser: British Menopause Society
Live Q&A webinar: Wednesday 3 November 16:00 – 17:30
Pre-recorded lecture videos and slides available: 26 October to 8 November 2021
We are delighted to offer our BMS Women’s Health Meeting with Mr Haitham Hamoda as a virtual meeting again this year. Together with Mr Hamoda, we have developed a full programme of lectures to provide you with up-to-date, evidence-based menopause and post-reproductive health education.
You will have access to pre-recorded videos of all the lectures, with lecture slides, for a two week period from 26 October to 8 November 2021. A 90 minute Zoom Q&A webinar will then be hosted by Mr Hamoda on Wednesday 3 November at 1600, giving you an opportunity to ask questions and reinforce your learning. You will be able to pre-submit questions via the BMS website programme page while you are viewing the lectures, for discussion during the Q&A webinar. The live Q&A webinar will be recorded and made available shortly after the event to watch at your convenience.
Healthcare professional delegates will also have access to a virtual exhibition. Participating healthcare and pharmaceutical companies will showcase their latest products with a range of literature and short videos.
The meeting carries 6 CPD credits and is open to all healthcare professionals – GPs, clinic doctors, gynaecologists, specialist and practice nurses, SRH specialists, O&G and GP trainees. We also welcome anyone allied to the healthcare profession with an interest in women’s health.
This Virtual BMS Women’s Health Meeting format launched successfully in 2020 and we are pleased to be able to offer you all the benefits of high-quality BMS education, with the versatility to learn at a time and location convenient to you.
|Further information:||Download online programme and registration form [PDF, 831KB]|
This meeting is financially supported in part by the pharmaceutical industry through sponsorship but it has no influence over the meeting agenda. All lecturers are required to make a formal declaration of interests at the beginning of their presentation.